Author

M. Poulin- Costello

Institutions: Cleveland Clinic, Providence Portland Medical Center, University of Chicago Medical Center, New York Oncology Hematology, Stanford University

Observed institutions: Cleveland Clinic, Providence Portland Medical Center, University of Chicago Medical Center, New York Oncology Hematology, Stanford University

OpenAlex ID: A5070085136

The Advanced Renal Cell Carcinoma Sorafenib (ARCCS) expanded access trial: Safety and efficacy in patients (pts) with non-clear cell (NCC) renal cell carcinoma (RCC)

2007 · W. M. Stadler, R. A. Figlin, et al. · Journal of Clinical Oncology · 40

Works count: 1

Citation count: 40

H-index: 1

I10-index: 1